Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide acts as a dual GLP-1/GIP agonist, while retatrutide adds glucagon receptor agonism as a third target
Research shows that men using 250-500 mcg daily for 12 weeks experience average increases of 25-30% in sperm concentration and 15-20% improvements in progressive motility
It is generally well tolerated and suitable for short- to medium-term use
10.1056/NEJMoa2401943 61 MaB.WangX.RenH.LiY.ZhangH.YangM.et al (2023)
Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity
US$ 23.78
US$ 22.82
US$ 25.49
US$ 25.71
US$ 27.47
US$ 28.23
